Skip to main content
NCBI home page
British Journal of Pharmacology logoLink to British Journal of Pharmacology
. 1984 Jun;82(Suppl):195P–348P.

Proceedings of the British Pharmacological Society. 11th-13th April, 1984. Abstracts.

PMCID: PMC1986870  PMID: 6733368

Full text

PDF
195P

Selected References

These references are in PubMed. This may not be the complete list of references from this article.

  1. ARUNLAKSHANA O., SCHILD H. O. Some quantitative uses of drug antagonists. Br J Pharmacol Chemother. 1959 Mar;14(1):48–58. doi: 10.1111/j.1476-5381.1959.tb00928.x. [DOI] [PMC free article] [PubMed] [Google Scholar]
  2. AXELROD J. Studies on sympathomimetic amines. II. The biotransformation and physiological disposition of d-amphetamine, d-p-hydroxyamphetamine and d-methamphetamine. J Pharmacol Exp Ther. 1954 Mar;110(3):315–326. [PubMed] [Google Scholar]
  3. Abe T., Kawai N., Miwa A. Effects of a spider toxin on the glutaminergic synapse of lobster muscle. J Physiol. 1983 Jun;339:243–252. doi: 10.1113/jphysiol.1983.sp014714. [DOI] [PMC free article] [PubMed] [Google Scholar]
  4. Al-Jibouri L. M., Furman B. L., Parratt J. R. Blockade of adrenaline-induced hyperglycaemia in the anaesthetized cat by continuous infusion of phentolamine and propranolol. Br J Pharmacol. 1980 Mar;68(3):461–466. doi: 10.1111/j.1476-5381.1980.tb14559.x. [DOI] [PMC free article] [PubMed] [Google Scholar]
  5. Allen J. T., Vaughan E. D., Jr, Gillenwater J. Y. The effect of indomethacin on renal blood flow and uretral pressure in unilateral ureteral obstruction in a awake dogs. Invest Urol. 1978 Jan;15(4):324–327. [PubMed] [Google Scholar]
  6. Antelman S. M., DeGiovanni L. A., Kocan D., Perel J. M., Chiodo L. A. Amitriptyline sensitization of a serotonin-mediated behavior depends on the passage of time and not repeated treatment. Life Sci. 1983 Oct 24;33(17):1727–1730. doi: 10.1016/0024-3205(83)90730-0. [DOI] [PubMed] [Google Scholar]
  7. Ault B., Nadler J. V. Effects of baclofen on synaptically-induced cell firing in the rat hippocampal slice. Br J Pharmacol. 1983 Sep;80(1):211–219. doi: 10.1111/j.1476-5381.1983.tb11068.x. [DOI] [PMC free article] [PubMed] [Google Scholar]
  8. Biegon A., Rainbow T. C., McEwen B. S. Quantitative autoradiography of serotonin receptors in the rat brain. Brain Res. 1982 Jun 24;242(2):197–204. doi: 10.1016/0006-8993(82)90301-8. [DOI] [PubMed] [Google Scholar]
  9. Borkowski K. R., Quinn P. The effect of bilateral adrenal demedullation on vascular reactivity and blood pressure in spontaneously hypertensive rats. Br J Pharmacol. 1983 Nov;80(3):429–437. doi: 10.1111/j.1476-5381.1983.tb10712.x. [DOI] [PMC free article] [PubMed] [Google Scholar]
  10. Bradley P. B., Dray A. Morphine and neurotransmitter substances: Microiontophoretic study in the rat brain stem. Br J Pharmacol. 1974 Jan;50(1):47–55. doi: 10.1111/j.1476-5381.1974.tb09591.x. [DOI] [PMC free article] [PubMed] [Google Scholar]
  11. Braestrup C., Squires R. F. Specific benzodiazepine receptors in rat brain characterized by high-affinity (3H)diazepam binding. Proc Natl Acad Sci U S A. 1977 Sep;74(9):3805–3809. doi: 10.1073/pnas.74.9.3805. [DOI] [PMC free article] [PubMed] [Google Scholar]
  12. Brown A. J., Casals-Stenzel J., Gofford S., Lever A. F., Morton J. J. Comparison of fast and slow pressor effects of angiotensin II in the conscious rat. Am J Physiol. 1981 Sep;241(3):H381–H388. doi: 10.1152/ajpheart.1981.241.3.H381. [DOI] [PubMed] [Google Scholar]
  13. Butcher R. L., Collins W. E., Fugo N. W. Plasma concentration of LH, FSH, prolactin, progesterone and estradiol-17beta throughout the 4-day estrous cycle of the rat. Endocrinology. 1974 Jun;94(6):1704–1708. doi: 10.1210/endo-94-6-1704. [DOI] [PubMed] [Google Scholar]
  14. Coker S. J., Parratt J. R. Nifedipine reduces arrhythmias but does not alter prostanoid release during coronary artery occlusion and reperfusion in anaesthetised greyhounds. J Cardiovasc Pharmacol. 1983 May-Jun;5(3):406–417. doi: 10.1097/00005344-198305000-00010. [DOI] [PubMed] [Google Scholar]
  15. Cox B., Lee T. F., Martin D. Different hypothalamic receptors mediate 5-hydroxytryptamine- and tryptamine-induced core temperature changes in the rat. Br J Pharmacol. 1981 Mar;72(3):477–482. doi: 10.1111/j.1476-5381.1981.tb10999.x. [DOI] [PMC free article] [PubMed] [Google Scholar]
  16. Davis L. E., Westfall B. A. Species differences in biotransformation and excretion of salicylate. Am J Vet Res. 1972 Jun;33(6):1253–1262. [PubMed] [Google Scholar]
  17. Detar R., Bohr D. F. Contractile responses of isolated vascular smooth muscle during prolonged exposure to anoxia. Am J Physiol. 1972 May;222(5):1269–1277. doi: 10.1152/ajplegacy.1972.222.5.1269. [DOI] [PubMed] [Google Scholar]
  18. Docherty J. R., O'Malley K. An examination of age-related changes in pre- and postsynaptic alpha-adrenoceptors in the rat isolated vas deferens. Eur J Pharmacol. 1983 Nov 25;95(3-4):171–176. doi: 10.1016/0014-2999(83)90631-3. [DOI] [PubMed] [Google Scholar]
  19. Doxey J. C., Roach A. G., Smith C. F. Studies on RX 781094: a selective, potent and specific antagonist of alpha 2-adrenoceptors. Br J Pharmacol. 1983 Mar;78(3):489–505. doi: 10.1111/j.1476-5381.1983.tb08809.x. [DOI] [PMC free article] [PubMed] [Google Scholar]
  20. Drucker-Colín R. R., Giacobini E. Sleep-inducing effect of piperidine. Brain Res. 1975 Apr 25;88(1):186–189. doi: 10.1016/0006-8993(75)90971-3. [DOI] [PubMed] [Google Scholar]
  21. Engel W. K., Siddique T., Nicoloff J. T. Effect on weakness and spasticity in amyotrophic lateral sclerosis of thyrotropin-releasing hormone. Lancet. 1983 Jul 9;2(8341):73–75. doi: 10.1016/s0140-6736(83)90060-0. [DOI] [PubMed] [Google Scholar]
  22. Euvrard C., Boissier J. R. Biochemical assessment of the central 5-HT agonist activity of RU 24969 (a piperidinyl indole). Eur J Pharmacol. 1980 Apr 11;63(1):65–72. doi: 10.1016/0014-2999(80)90117-x. [DOI] [PubMed] [Google Scholar]
  23. Feniuk W., Humphrey P. P., Watts A. D. 5-Hydroxytryptamine-induced relaxation of isolated mammalian smooth muscle. Eur J Pharmacol. 1983 Dec 9;96(1-2):71–78. doi: 10.1016/0014-2999(83)90530-7. [DOI] [PubMed] [Google Scholar]
  24. File S. E., Lister R. G. The anxiogenic action of Ro 5-4864 is reversed by phenytoin. Neurosci Lett. 1983 Jan 31;35(1):93–96. doi: 10.1016/0304-3940(83)90532-3. [DOI] [PubMed] [Google Scholar]
  25. Fozard J. R. Mechanism of the hypotensive effect of ketanserin. J Cardiovasc Pharmacol. 1982 Sep-Oct;4(5):829–838. doi: 10.1097/00005344-198209000-00020. [DOI] [PubMed] [Google Scholar]
  26. Furr B. J., Nicholson R. I. Use of analogues of luteinizing hormone-releasing hormone for the treatment of cancer. J Reprod Fertil. 1982 Mar;64(2):529–539. doi: 10.1530/jrf.0.0640529. [DOI] [PubMed] [Google Scholar]
  27. Gillespie J. S., Maclaren A., Pollock D. A method of stimulating different segments of the autonomic outflow from the spinal column to various organs in the pithed cat and rat. Br J Pharmacol. 1970 Oct;40(2):257–267. doi: 10.1111/j.1476-5381.1970.tb09919.x. [DOI] [PMC free article] [PubMed] [Google Scholar]
  28. Gillespie J. S., Maclaren A., Pollock D. A method of stimulating different segments of the autonomic outflow from the spinal column to various organs in the pithed cat and rat. Br J Pharmacol. 1970 Oct;40(2):257–267. doi: 10.1111/j.1476-5381.1970.tb09919.x. [DOI] [PMC free article] [PubMed] [Google Scholar]
  29. Grahame-Smith D. G. Inhibitory effect of chlorpromazine on the syndrome of hyperactivity produced by L-tryptophan or 5-methoxy-N,N-dimethyltryptamine in rats treated with a monoamine oxidase inhibitor. Br J Pharmacol. 1971 Dec;43(4):856–864. doi: 10.1111/j.1476-5381.1971.tb07222.x. [DOI] [PMC free article] [PubMed] [Google Scholar]
  30. Green A. R., O'Shaughnessy K., Hammond M., Schächter M., Grahame-Smith D. G. Inhibition of 5-hydroxytryptamine-mediated behaviour by the putative 5-HT2 antagonist pirenperone. Neuropharmacology. 1983 May;22(5):573–578. doi: 10.1016/0028-3908(83)90147-8. [DOI] [PubMed] [Google Scholar]
  31. HABERLAND G. L., MEDENWALD H., KOSTER L. Stoffwechseluntersuchungen an Pharmazeutika. II. Stoffwechselendprodukte der Salicyl-, Acetylsalicyl-, Gentisin- und Salicylursäure im Rattenurin. Hoppe Seylers Z Physiol Chem. 1957 Feb 5;306(4-6):235–246. [PubMed] [Google Scholar]
  32. Haas H. L., Konnerth A. Histamine and noradrenaline decrease calcium-activated potassium conductance in hippocampal pyramidal cells. 1983 Mar 31-Apr 6Nature. 302(5907):432–434. doi: 10.1038/302432a0. [DOI] [PubMed] [Google Scholar]
  33. Holmlund D., Sjödin J. G. Treatment of ureteral colic with intravenous indomethacin. J Urol. 1978 Dec;120(6):676–677. doi: 10.1016/s0022-5347(17)57325-5. [DOI] [PubMed] [Google Scholar]
  34. Jones R. S., Olpe H. R. Altered sensitivity of forebrain neurones to iontophoretically applied noradrenaline in aging rats. Neurobiol Aging. 1983 Spring;4(1):97–99. doi: 10.1016/0197-4580(83)90060-x. [DOI] [PubMed] [Google Scholar]
  35. Levy G. Pharmacokinetics of salicylate in man. Drug Metab Rev. 1979;9(1):3–19. doi: 10.3109/03602537909046431. [DOI] [PubMed] [Google Scholar]
  36. Leysen J. E., Awouters F., Kennis L., Laduron P. M., Vandenberk J., Janssen P. A. Receptor binding profile of R 41 468, a novel antagonist at 5-HT2 receptors. Life Sci. 1981 Mar 2;28(9):1015–1022. doi: 10.1016/0024-3205(81)90747-5. [DOI] [PubMed] [Google Scholar]
  37. Leysen J. E., Niemegeers C. J., Van Nueten J. M., Laduron P. M. [3H]Ketanserin (R 41 468), a selective 3H-ligand for serotonin2 receptor binding sites. Binding properties, brain distribution, and functional role. Mol Pharmacol. 1982 Mar;21(2):301–314. [PubMed] [Google Scholar]
  38. Leysen J. E., Niemegeers C. J., Van Nueten J. M., Laduron P. M. [3H]Ketanserin (R 41 468), a selective 3H-ligand for serotonin2 receptor binding sites. Binding properties, brain distribution, and functional role. Mol Pharmacol. 1982 Mar;21(2):301–314. [PubMed] [Google Scholar]
  39. Majewski H., Tung L. H., Rand M. J. Adrenaline-induced hypertension in rats. J Cardiovasc Pharmacol. 1981 Jan-Feb;3(1):179–185. doi: 10.1097/00005344-198101000-00016. [DOI] [PubMed] [Google Scholar]
  40. Marangos P. J., Patel J., Boulenger J. P., Clark-Rosenberg R. Characterization of peripheral-type benzodiazepine binding sites in brain using [3H]Ro 5-4864. Mol Pharmacol. 1982 Jul;22(1):26–32. [PubMed] [Google Scholar]
  41. McCarley R. W., Hobson J. A. Neuronal excitability modulation over the sleep cycle: a structural and mathematical model. Science. 1975 Jul 4;189(4196):58–60. doi: 10.1126/science.1135627. [DOI] [PubMed] [Google Scholar]
  42. McGrath J. C., Flavahan N. A., McKean C. E. alpha 1- and alpha 2-Adrenoceptor-mediated pressor and chronotropic effects in the rat and rabbit. J Cardiovasc Pharmacol. 1982;4 (Suppl 1):S101–S107. doi: 10.1097/00005344-198200041-00021. [DOI] [PubMed] [Google Scholar]
  43. McGrath J. C., Flavahan N. A., McKean C. E. alpha 1- and alpha 2-Adrenoceptor-mediated pressor and chronotropic effects in the rat and rabbit. J Cardiovasc Pharmacol. 1982;4 (Suppl 1):S101–S107. doi: 10.1097/00005344-198200041-00021. [DOI] [PubMed] [Google Scholar]
  44. Meites J., Cassell E., Clark J. Estrogen inhibition of mammary tumor growth in rats; counteraction by prolactin. Proc Soc Exp Biol Med. 1971 Sep;137(4):1225–1227. doi: 10.3181/00379727-137-35760. [DOI] [PubMed] [Google Scholar]
  45. Mesdjian E., DeFeudis F. V., Valli M., Jadot G., Mandel P. Antinociceptive action of sodium valproate in the mouse. Gen Pharmacol. 1983;14(6):697–699. doi: 10.1016/0306-3623(83)90172-6. [DOI] [PubMed] [Google Scholar]
  46. Miyata T., Okano Y., Fukunaga K., Takahama K., Kasé Y. Seasonal and activity-dependent variations of piperidine levels in the amphibian brain. Brain Res. 1980 Sep 15;197(1):279–284. doi: 10.1016/0006-8993(80)90460-6. [DOI] [PubMed] [Google Scholar]
  47. Miyata T., Okano Y., Murao K., Fukunaga K., Takahama K., Kasé Y. Analysis of physiological variations of piperidine levels in tissues by mass fragmentography. Life Sci. 1979 Nov 12;25(20):1731–1738. doi: 10.1016/0024-3205(79)90476-4. [DOI] [PubMed] [Google Scholar]
  48. Moratinos J., Potter D. E., Ellis S. The influence of propranolol on catecholamine-induced changes in carbohydrate metabolism in the rabbit. Eur J Pharmacol. 1975 Jun-Jul;32(02):186–194. doi: 10.1016/0014-2999(75)90282-4. [DOI] [PubMed] [Google Scholar]
  49. Nakadate T., Nakaki T., Muraki T., Kato R. Regulation of plasma insulin level by alpha 2-adrenergic receptors. Eur J Pharmacol. 1980 Aug 8;65(4):421–424. doi: 10.1016/0014-2999(80)90347-7. [DOI] [PubMed] [Google Scholar]
  50. Nausieda P. A., Carvey P. M., Weiner W. J. Modification of central serotonergic and dopaminergic behaviors in the course of chronic corticosteroid administration. Eur J Pharmacol. 1982 Mar 12;78(3):335–343. doi: 10.1016/0014-2999(82)90035-8. [DOI] [PubMed] [Google Scholar]
  51. Nayler W. G., Fassold E., Yepez C. Pharmacological protection of mitochondrial function in hypoxic heart muscle: Effect of verapamil, propranolol, and methylprednisolone. Cardiovasc Res. 1978 Mar;12(3):152–161. doi: 10.1093/cvr/12.3.152. [DOI] [PubMed] [Google Scholar]
  52. Olsen R. W. Drug interactions at the GABA receptor-ionophore complex. Annu Rev Pharmacol Toxicol. 1982;22:245–277. doi: 10.1146/annurev.pa.22.040182.001333. [DOI] [PubMed] [Google Scholar]
  53. Peck M. J., Piper P. J., Williams T. J. The effect of leukotrienes C4 and D4 on the microvasculature of guinea-pig skin. Prostaglandins. 1981 Feb;21(2):315–321. doi: 10.1016/0090-6980(81)90149-0. [DOI] [PubMed] [Google Scholar]
  54. Peroutka S. J., Snyder S. H. Long-term antidepressant treatment decreases spiroperidol-labeled serotonin receptor binding. Science. 1980 Oct 3;210(4465):88–90. doi: 10.1126/science.6251550. [DOI] [PubMed] [Google Scholar]
  55. Peroutka S. J., Snyder S. H. Multiple serotonin receptors: differential binding of [3H]5-hydroxytryptamine, [3H]lysergic acid diethylamide and [3H]spiroperidol. Mol Pharmacol. 1979 Nov;16(3):687–699. [PubMed] [Google Scholar]
  56. Peroutka S. J., Snyder S. H. Multiple serotonin receptors: differential binding of [3H]5-hydroxytryptamine, [3H]lysergic acid diethylamide and [3H]spiroperidol. Mol Pharmacol. 1979 Nov;16(3):687–699. [PubMed] [Google Scholar]
  57. Rogawski M. A., Aghajanian G. K. Modulation of lateral geniculate neurone excitability by noradrenaline microiontophoresis or locus coeruleus stimulation. Nature. 1980 Oct 23;287(5784):731–734. doi: 10.1038/287731a0. [DOI] [PubMed] [Google Scholar]
  58. Sakurada A., Voss D. O., Brandão D., Campello A. P. Effects of propranolol on heart muscle mitochondria. Biochem Pharmacol. 1972 Feb 15;21(4):535–540. doi: 10.1016/0006-2952(72)90327-9. [DOI] [PubMed] [Google Scholar]
  59. Sanchez-Chapula J. Multiple effects of putative alpha-adrenoceptor agonists on the electrical and mechanical activity of guinea-pig papillary muscle. Naunyn Schmiedebergs Arch Pharmacol. 1981 Apr;316(2):108–111. doi: 10.1007/BF00505302. [DOI] [PubMed] [Google Scholar]
  60. Sasamoto S., Sato K., Neito H. Biological active life of PMSG in mice with special reference to follicular ability to ovulate. J Reprod Fertil. 1972 Sep;30(3):371–379. doi: 10.1530/jrf.0.0300371. [DOI] [PubMed] [Google Scholar]
  61. Saxena P. R., Verdouw P. D. Redistribution by 5-hydroxytryptamine of carotid arterial blood at the expense of arteriovenous anastomotic blood flow. J Physiol. 1982 Nov;332:501–520. doi: 10.1113/jphysiol.1982.sp014427. [DOI] [PMC free article] [PubMed] [Google Scholar]
  62. Saxena P. R., Verdouw P. D. Redistribution by 5-hydroxytryptamine of carotid arterial blood at the expense of arteriovenous anastomotic blood flow. J Physiol. 1982 Nov;332:501–520. doi: 10.1113/jphysiol.1982.sp014427. [DOI] [PMC free article] [PubMed] [Google Scholar]
  63. Sharif N. A., Burt D. R. Receptors for thyrotropin-releasing hormone (TRH) in rabbit spinal cord. Brain Res. 1983 Jul 4;270(2):259–263. doi: 10.1016/0006-8993(83)90599-1. [DOI] [PubMed] [Google Scholar]
  64. Sharif N. A., Burt D. R., Towle A. C., Mueller R. A., Breese G. R. Codepletion of serotonin and TRH induces apparent supersensitivity of spinal TRH receptors. Eur J Pharmacol. 1983 Nov 25;95(3-4):301–304. doi: 10.1016/0014-2999(83)90651-9. [DOI] [PubMed] [Google Scholar]
  65. Simmonds M. A. Evidence that bicuculline and picrotoxin act at separate sites to antagonize gamma-aminobutyric acid in rat cuneate nucleus. Neuropharmacology. 1980 Jan;19(1):39–45. doi: 10.1016/0028-3908(80)90164-1. [DOI] [PubMed] [Google Scholar]
  66. Simmonds M. A. Evidence that bicuculline and picrotoxin act at separate sites to antagonize gamma-aminobutyric acid in rat cuneate nucleus. Neuropharmacology. 1980 Jan;19(1):39–45. doi: 10.1016/0028-3908(80)90164-1. [DOI] [PubMed] [Google Scholar]
  67. Sobel B., Jequier E., Sjoerdsma A., Lovenberg W. Effect of catecholamines and adrenergic blocking agents on oxidative phosphorylation in rat heart mitochondria. Circ Res. 1966 Dec;19(6):1050–1061. doi: 10.1161/01.res.19.6.1050. [DOI] [PubMed] [Google Scholar]
  68. Soter N. A., Lewis R. A., Corey E. J., Austen K. F. Local effects of synthetic leukotrienes (LTC4, LTD4, LTE4, and LTB4) in human skin. J Invest Dermatol. 1983 Feb;80(2):115–119. doi: 10.1111/1523-1747.ep12531738. [DOI] [PubMed] [Google Scholar]
  69. Starke K., Borowski E., Endo T. Preferential blockade of presynaptic alpha-adrenoceptors by yohimbine. Eur J Pharmacol. 1975 Dec;34(2):385–388. doi: 10.1016/0014-2999(75)90268-x. [DOI] [PubMed] [Google Scholar]
  70. Stolz J. F., Marsden C. A. Withdrawal from chronic treatment with metergoline, dl-propranolol and amitriptyline enhances serotonin receptor mediated behaviour in the rat. Eur J Pharmacol. 1982 Apr 8;79(1-2):17–22. doi: 10.1016/0014-2999(82)90570-2. [DOI] [PubMed] [Google Scholar]
  71. Taylor E. A., Turner P. The distribution of propranolol, pindolol and atenolol between human erythrocytes and plasma. Br J Clin Pharmacol. 1981 Oct;12(4):543–548. doi: 10.1111/j.1365-2125.1981.tb01263.x. [DOI] [PMC free article] [PubMed] [Google Scholar]
  72. Ueno A., Tanaka K., Katori M., Hayashi M., Arai Y. Species difference in increased vascular permeability by synthetic leukotriene C4 and D4. Prostaglandins. 1981 Apr;21(4):637–648. doi: 10.1016/0090-6980(81)90012-5. [DOI] [PubMed] [Google Scholar]
  73. Van Meel J. C., De Jonge A., Kalkman H. O., Wilffert B., Timmermans P. B., Van Zwieten P. A. Vascular smooth muscle contraction initiated by postsynaptic alpha 2-adrenoceptor activation is induced by an influx of extracellular calcium. Eur J Pharmacol. 1981 Jan 16;69(2):205–208. doi: 10.1016/0014-2999(81)90415-5. [DOI] [PubMed] [Google Scholar]
  74. Vetulani J., Sulser F. Action of various antidepressant treatments reduces reactivity of noradrenergic cyclic AMP-generating system in limbic forebrain. Nature. 1975 Oct 9;257(5526):495–496. doi: 10.1038/257495a0. [DOI] [PubMed] [Google Scholar]
  75. Waeber B., Nussberger J., Brunner H. R. Blood pressure dependency on vasopressin and angiotensin II in prazosin-treated conscious normotensive rats. J Pharmacol Exp Ther. 1983 May;225(2):442–446. [PubMed] [Google Scholar]
  76. Wagner J., Brodde O. E. On the presence and distribution of alpha-adrenoceptors in the heart of various mammalian species. Naunyn Schmiedebergs Arch Pharmacol. 1978 May;302(3):239–254. doi: 10.1007/BF00508293. [DOI] [PubMed] [Google Scholar]
  77. Waterhouse B. D., Moises H. C., Woodward D. J. Alpha-receptor-mediated facilitation of somatosensory cortical neuronal responses to excitatory synaptic inputs and iontophoretically applied acetylcholine. Neuropharmacology. 1981 Oct;20(10):907–920. doi: 10.1016/0028-3908(81)90020-4. [DOI] [PubMed] [Google Scholar]
  78. Woodward D. F., Owen D. A. Studies on histamine-induced cutaneous flare in the guinea pig. Agents Actions. 1983 Feb;13(1):35–44. doi: 10.1007/BF01994279. [DOI] [PubMed] [Google Scholar]
  79. Zaagsma J., van der Heijden P. J., van der Schaar M. W., Bank C. M. Comparison of functional beta-adrenoceptor heterogeneity in central and peripheral airway smooth muscle of guinea pig and man. J Recept Res. 1983;3(1-2):89–106. doi: 10.3109/10799898309041925. [DOI] [PubMed] [Google Scholar]
  80. Zukin R. S., Zukin S. R. Demonstration of [3H]cyclazocine binding to multiple opiate receptor sites. Mol Pharmacol. 1981 Sep;20(2):246–254. [PubMed] [Google Scholar]

Articles from British Journal of Pharmacology are provided here courtesy of The British Pharmacological Society

RESOURCES